Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43

Polymenidou, Magdalini, Lagier-Tourenne, Clotilde, Hutt, Kasey R, Huelga, Stephanie C, Moran, Jacqueline, Liang, Tiffany Y, Ling, Shuo-Chien, Sun, Eveline +9 more·2011·Nature Neuroscience
DOI 10.1038/nn.2779

Cited by (1,001)

Items 301–400 of 1,001

  1. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients
    Mahlon A. Collins, David Riascos, Tina Kovalik, Jiyan An, Kelly Krupa, Kristin Krupa, Brian L. Hood, Thomas P. Conrads, Alan Edward Renton, Bryan J. Traynor et al. · 2012 · Acta Neuropathologica
  2. Alteration of POLDIP3 Splicing Associated with Loss of Function of TDP-43 in Tissues Affected with ALS
    Atsushi Shiga, Tomohiko Ishihara, Akinori Miyashita, Misaki Kuwabara, Taisuke Kato, Norihiro Watanabe, Akie Yamahira, Chigusa Kondo, Akio Yokoseki, Masuhiro Takahashi et al. · 2012 · PLoS ONE
  3. Prevention of intestinal obstruction reveals progressive neurodegeneration in mutant TDP-43 (A315T)mice
    Sarah Herdewyn, Carla Cirillo, Ludo Van Den Bosch, Wim Robberecht, Pieter Vanden Berghe, Philip Van Damme · 2014 · Molecular Neurodegeneration
  4. Cell-autonomous requirement of TDP-43, an ALS/FTD signature protein, for oligodendrocyte survival and myelination
    Jia Wang, Wan Yun Ho, Kenneth Lim, Jia Feng, Greg Tucker‐Kellogg, Klaus‐Armin Nave, Shuo‐Chien Ling · 2018 · Proceedings of the National Academy of Sciences
  5. RNA-mediated toxicity in neurodegenerative disease
    Véronique Belzil, Tania F. Gendron, Leonard Petrucelli · 2012 · Molecular and Cellular Neuroscience
  6. TDP-43 in central nervous system development and function: clues to TDP-43-associated neurodegeneration
    Sephton, Chantelle F., Cenik, Basar, Cenik, Bercin Kutluk, Herz, Joachim, Yu, Gang · 2012 · bchm
  7. Low molecular weight species of TDP-43 generated by abnormal splicing form inclusions in amyotrophic lateral sclerosis and result in motor neuron death
    Shangxi Xiao, Teresa R. Sanelli, Helen Yu-Shan Chiang, Yulong Sun, Avijit Chakrabartty, Julia Lee Keith, Ekaterina A. Rogaeva, Lorne H. Zinman, Janice Robertson · 2015 · Acta Neuropathologica
  8. Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism
    Erin G. Conlon, Delphine Fagegaltier, Phaedra Agius, Julia Davis‐Porada, James A. Gregory, Isabel Hubbard, Kristy Kang, Duyang Kim, Hemali P. Phatnani, Justin Y. Kwan et al. · 2018 · eLife
  9. Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis
    Shuo‐Chien Ling, Somasish Ghosh Dastidar, Seiya Tokunaga, Wan Yun Ho, Kenneth Lim, Hristelina S. Ilieva, Philippe A. Parone, Sheue-Houy Tyan, Tsemay M. Tse, Jer‐Cherng Chang et al. · 2019 · eLife
  10. Identification of RNA bound to the TDP-43 ribonucleoprotein complex in the adult mouse brain
    Ramesh K. Narayanan, Marie Mangelsdorf, Ajay Panwar, Tim J. Butler, Peter G. Noakes, Robyn H. Wallace · 2012 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  11. Disease causing mutants of TDP-43 nucleic acid binding domains are resistant to aggregation and have increased stability and half-life
    James A. Austin, Gareth S. A. Wright, Seiji Watanabe, Jörg Günter Grossmann, S.V. Antonyuk, Koji Yamanaka, S.S. Hasnain · 2014 · Proceedings of the National Academy of Sciences
  12. TDP-43 functions within a network of hnRNP proteins to inhibit the production of a truncated human SORT1 receptor
    Fatemeh Mohagheghi, Mercedes Prudencio, Cristiana Stuani, Casey N. Cook, Karen R. Jansen‐West, Dennis W. Dickson, Leonard Petrucelli, Emanuele Buratti · 2015 · Human Molecular Genetics
  13. Perspective in Alternative Splicing Coupled to Nonsense-Mediated mRNA Decay
    Juan F. García-Moreno, Luı́sa Romão · 2020 · International Journal of Molecular Sciences
  14. Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis
    Kyla A. Britson, Jonathan P. Ling, Kerstin E. Braunstein, Janelle Marie Montagne, Jenna M. Kastenschmidt, Andrew Wilson, Chiseko Ikenaga, William Tsao, Iago Pinal‐Fernandez, Katelyn A. Russell et al. · 2022 · Science Translational Medicine
  15. C9orf72-FTD/ALS pathogenesis: evidence from human neuropathological studies
    Sarat C. Vatsavayai, Alissa L. Nana, Jennifer S. Yokoyama, William W. Seeley · 2018 · Acta Neuropathologica
  16. Nucleocytoplasmic Proteomic Analysis Uncovers eRF1 and Nonsense-Mediated Decay as Modifiers of ALS/FTD C9orf72 Toxicity
    Juan Alberto Ortega, Elizabeth L. Daley, Sukhleen Kour, Marisa Samani, Liana Tellez, Haley S. Smith, Elizabeth Hall, Y. Taylan Esengul, Yung‐Hsu Tsai, Tania F. Gendron et al. · 2020 · Neuron
  17. Molecular mechanism of oxidation‐induced TDP‐43 RRM1 aggregation and loss of function
    Chung‐ke Chang, Ming-hui Chiang, Elsie Khai-Woon Toh, Chi‐Fon Chang, Tai-huang Huang · 2013 · FEBS Letters
  18. Emerging Therapies and Novel Targets for TDP-43 Proteinopathy in ALS/FTD
    Lindsey R. Hayes, Petr Kaláb · 2022 · Neurotherapeutics
  19. The molecular link between inefficient GluA2 Q/R site-RNA editing and TDP-43 pathology in motor neurons of sporadic amyotrophic lateral sclerosis patients
    Takenari Yamashita, Shin Kwak · 2013 · Brain Research
  20. Biology and Pathobiology of TDP-43 and Emergent Therapeutic Strategies
    Lin E. Guo, James Shorter · 2016 · Cold Spring Harbor Perspectives in Medicine
  21. Synaptic Paths to Neurodegeneration: The Emerging Role of TDP-43 and FUS in Synaptic Functions
    Shuo‐Chien Ling · 2018 · Neural Plasticity
  22. TDP-43 transports ribosomal protein mRNA to regulate axonal local translation in neuronal axons
    Seiichi Nagano, Junki Jinno, Rehab F. Abdelhamid, Yinshi Jin, Megumi Shibata, Shohei Watanabe, Sachiko Hirokawa, Masatoyo Nishizawa, Kenji Sakimura, Osamu Onodera et al. · 2020 · Acta Neuropathologica
  23. Post-transcriptional regulation of long noncoding RNAs in cancer
    Xuefei Shi, Ming Sun, Ying Wu, Yanwen Yao, Hongbing Liu, Guannan Wu, Dongmei Yuan, Yong Song · 2015 · Tumor Biology
  24. Calcium Channel Agonists Protect against Neuromuscular Dysfunction in a Genetic Model of TDP-43 Mutation in ALS
    Gary A.B. Armstrong, Pierre Drapeau · 2013 · Journal of Neuroscience
  25. Drosophila TDP-43 dysfunction in glia and muscle cells cause cytological and behavioural phenotypes that characterize ALS and FTLD
    Danielle C. Diaper, Yoshitsugu Adachi, Luke Lazarou, Max Greenstein, Fabio A. Simoes, Angelique di Domenico, Daniel A. Solomon, Simon A. Lowe, Rawan AlSubaie, Daryl Cheng et al. · 2013 · Human Molecular Genetics
  26. Astrocytic TDP-43 Pathology in Alexander Disease
    Adam K. Walker, Christine M. LaPash Daniels, James E. Goldman, John Q. Trojanowski, Virginia M.‐Y. Lee, Albee Messing · 2014 · Journal of Neuroscience
  27. TDP-43 affects splicing profiles and isoform production of genes involved in the apoptotic and mitotic cellular pathways
    Laura De Conti, Maureen V. Akinyi, Ramiro Mendoza-Maldonado, Maurizio Romano, Marco Baralle, Emanuele Buratti · 2015 · Nucleic Acids Research
  28. TDP-43 suppresses tau expression via promoting its mRNA instability
    Jianlan Gu, Feng Wu, Wen Xu, Jianhua Shi, Wen Hui Hu, Nana Jin, Wei Qian, Xinglong Wang, Khalid Iqbal, Cheng‐Xin Gong et al. · 2017 · Nucleic Acids Research
  29. Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer’s disease
    Ana Rita Agra de Almeida Quadros, Zhaozhi Li, Xue Wang, I. Sandra Ndayambaje, Sandeep Aryal, Nandini Ramesh, Matthew Nolan, Rojashree Jayakumar, Yi Han, Hannah Stillman et al. · 2024 · Acta Neuropathologica
  30. RNA-binding proteins in neurological diseases
    Hua-Lin Zhou, Marie Mangelsdorf, JiangHong Liu, Li Zhu, Jane Y. Wu · 2014 · Science China Life Sciences
  31. RNA binding mediates neurotoxicity in the transgenic Drosophila model of TDP-43 proteinopathy
    Ryoko Ihara, Koji Matsukawa, Yusei Nagata, Hayato Kunugi, Shoji Tsuji, Takahiro Chihara, Erina Kuranaga, Masayuki Miura, Tomoko Wakabayashi, Tadafumi Hashimoto et al. · 2013 · Human Molecular Genetics
  32. Post-translational modifications on RNA-binding proteins: accelerators, brakes, or passengers in neurodegeneration?
    Erin L. Sternburg, Lara A. Gruijs da Silva, Dorothee Dormann · 2021 · Trends in Biochemical Sciences
  33. A robust TDP-43 knock-in mouse model of ALS
    Shih‐Ling Huang, Lien-Szu Wu, Min Lee, Chin-Wen Chang, Wei-Cheng Cheng, Yu-Sheng Fang, Yun‐Ru Chen, Pei‐Lin Cheng, Che-Kun James Shen · 2020 · Acta Neuropathologica Communications
  34. Preservation of forelimb function by UPF1 gene therapy in a rat model of TDP-43-induced motor paralysis
    Kasey L. Jackson, Robert D. Dayton, Elysse A. Orchard, Shulin Ju, Dagmar Ringe, Gregory A. Petsko, Lynne E. Maquat, Ronald L. Klein · 2014 · Gene Therapy
  35. Motor neurons and glia exhibit specific individualized responses to TDP-43 expression in a Drosophila model of amyotrophic lateral sclerosis
    Patricia S. Estes, Scott G. Daniel, Abigail P. McCallum, Ashley V. Boehringer, Alona S. Sukhina, Rebecca A. Zwick, Daniela C. Zarnescu · 2013 · Disease Models & Mechanisms
  36. Design and bioinformatics analysis of genome-wide CLIP experiments
    Tongshan Wang, Guanghua Xiao, Yongjun Chu, M. Q. Zhang, David R. Corey, Yang Xie · 2015 · Nucleic Acids Research
  37. Exploring new pathways of neurodegeneration in ALS: The role of mitochondria quality control
    Gloria M. Palomo, Giovanni Manfredi · 2014 · Brain Research
  38. RNA dysfunction and aggrephagy at the centre of an amyotrophic lateral sclerosis/frontotemporal dementia disease continuum
    Matthew Thomas, Javier Alegre‐Abarrategui, Richard Wade‐Martins · 2013 · Brain
  39. The roles of intrinsic disorder-based liquid-liquid phase transitions in the “Dr. Jekyll–Mr. Hyde” behavior of proteins involved in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
    Vladimir Nikolaevich Uversky · 2017 · Autophagy
  40. TDP-43 mediated blood-brain barrier permeability and leukocyte infiltration promote neurodegeneration in a low-grade systemic inflammation mouse model
    Frank Zamudio, Anjanet R. Loon, Shayna Smeltzer, Khawla Benyamine, Nanda Kumar N. Shanmugam, Nicholas J. Stewart, Daniel C. Lee, Kevin R. Nash, Maj‐Linda B. Selenica · 2020 · Journal of Neuroinflammation
  41. Loss of TDP-43 in astrocytes leads to motor deficits by triggering A1-like reactive phenotype and triglial dysfunction
    Audrey Yi Tyan Peng, Ira Agrawal, Wan Yun Ho, Yi-Chun Yen, Ashley J. Pinter, Jerry Liu, Qi Xuan Cheryl Phua, Katrianne Bethia Koh, Jer‐Cherng Chang, Emma Sanford et al. · 2020 · Proceedings of the National Academy of Sciences
  42. New pathogenic insights from large animal models of neurodegenerative diseases
    Peng Yin, Shihua Li, Xiao‐Jiang Li, Weili Yang · 2022 · Protein & Cell
  43. The role of TDP-43 in the pathogenesis of ALS and FTLD
    Marco Baralle, Emanuele Buratti, Francisco Ernesto Baralle · 2013 · Biochemical Society Transactions
  44. Conjoint pathologic cascades mediated by ALS/FTLD-U linked RNA-binding proteins TDP-43 and FUS
    Daisuke Ito, Norihiro Suzuki · 2011 · Neurology
  45. Neurodegenerative diseases: Quantitative predictions of protein–RNA interactions
    Davide Cirillo, Federico Agostini, Petr Klus, Doménica Marchese, Sílvia Rodriguez-Mulero, Benedetta Bolognesi, Gian Gaetano Tartaglia · 2012 · RNA
  46. Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells
    Chiara Appocher, Fatemeh Mohagheghi, Sara Cappelli, Cristiana Stuani, Maurizio Romano, Fabian M. Feiguin, Emanuele Buratti · 2017 · Nucleic Acids Research
  47. Trafficking in Alzheimer’s Disease: Modulation of APP Transport and Processing by the Transmembrane Proteins LRP1, SorLA, SorCS1c, Sortilin, and Calsyntenin
    Simone Eggert, Carolin Thomas, Stefan Kins, Guido Hermey · 2017 · Molecular Neurobiology
  48. Altered mRNP granule dynamics in FTLD pathogenesis
    Hilary A. Bowden, Dorothee Dormann · 2016 · Journal of Neurochemistry
  49. The cooperative binding of TDP-43 to GU-rich RNA repeats antagonizes TDP-43 aggregation
    Juan Carlos Rengifo-Gonzalez, Krystel El Hage, Marie‐Jeanne Clément, Emilie Steiner, Vandana Joshi, Pierrick Craveur, DURAND Dominique Christiane, David Pastré, Ahmed Bouhss · 2021 · eLife
  50. TDP-43 pathology: From noxious assembly to therapeutic removal
    Sean S. Keating, Rebecca San Gil, Molly E. V. Swanson, Emma L. Scotter, Adam K. Walker · 2022 · Progress in Neurobiology
  51. Monomerization of TDP-43 is a key determinant for inducing TDP-43 pathology in amyotrophic lateral sclerosis
    Kotaro Oiwa, Seiji Watanabe, Kazunari Onodera, Yohei Iguchi, Yukako Kinoshita, Okiru Komine, Akira Sobue, Yohei Okada, Masahisa Katsuno, Koji Yamanaka · 2023 · Science Advances
  52. PPAR gamma activation is neuroprotective in a Drosophila model of ALS based on TDP-43
    Archi Joardar, Judith Menzl, Taylor Catherine Podolsky, Ernesto Manzo, Patricia S. Estes, Sarah Ashford, Daniela C. Zarnescu · 2014 · Human Molecular Genetics
  53. Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs
    Hawrot, James, Imhof, Sophie, Wainger, Brian J. · 2020 · Neurobiology of Disease
  54. Interaction of RNA with a C-terminal fragment of the amyotrophic lateral sclerosis-associated TDP43 reduces cytotoxicity
    Akira Kitamura, Yusaku Nakayama, Ai Shibasaki, Ayami Taki, Sachiko Yuno, Kayo Takeda, Masao Yahara, Naoki Tanabe, Masataka Kinjo · 2016 · Scientific Reports
  55. Proteostatic imbalance and protein spreading in amyotrophic lateral sclerosis
    M.E. Cicardi, Lara Marrone, Mimoun Azzouz, Davide Trotti · 2021 · The EMBO Journal
  56. Decreased number of Gemini of coiled bodies and U12 snRNA level in amyotrophic lateral sclerosis
    Tomohiko Ishihara, Yuko Ariizumi, Atsushi Shiga, Taisuke Kato, Chun‐Feng Tan, Tatsuya Sato, Yukari Miki, Mariko Yokoo, Takeshi Fujino, Akihide Koyama et al. · 2013 · Human Molecular Genetics
  57. Neurodegeneration the RNA way
    Abigail J. Renoux, Peter K. Todd · 2011 · Progress in Neurobiology
  58. Impaired protein degradation in FTLD and related disorders
    Julia K Götzl, Christina M. Lang, Christian Haass, Anja Capell · 2016 · Ageing Research Reviews
  59. TDP-43 dysfunction results in R-loop accumulation and DNA replication defects
    Matthew D. Wood, Annabel Quinet, Yi‐Ching Lin, Albert A. Davis, Philippe Pasero, Yuna M. Ayala, Alessandro Vindigni · 2020 · Journal of Cell Science
  60. Synaptic FUS accumulation triggers early misregulation of synaptic RNAs in a mouse model of ALS
    Sonu Sahadevan, Katharina Hembach, Elena Tantardini, Manuela Pérez‐Berlanga, Marián Hruška-Plocháň, Salim Megat, Julien Weber, Petra Schwarz, Luc Dupuis, Mark D. Robinson et al. · 2021 · Nature Communications
  61. Cell‐to‐cell transmission of C9orf72 poly‐(Gly‐Ala) triggers key features of ALS/FTD
    Bahram Khosravi, Kathrine D LaClair, Henrick Riemenschneider, Qihui Zhou, Frédéric Frottin, Nikola Mareljic, Mareike Czuppa, Daniel Farny, Hannelore Hartmann, Meike Michaelsen et al. · 2020 · The EMBO Journal
  62. TDP‐1, the Caenorhabditis elegans ortholog of TDP‐43, limits the accumulation of double‐stranded RNA
    Saldi, Tassa K, Ash, Peter EA, Wilson, Gavin, Gonzales, Patrick, Garrido‐Lecca, Alfonso, Roberts, Christine M, Dostal, Vishantie, Gendron, Tania F, Stein, Lincoln D, Blumenthal, Thomas et al. · 2014 · The EMBO Journal
  63. Caenorhabditis elegans RNA-processing Protein TDP-1 Regulates Protein Homeostasis and Life Span
    Tāo Zhāng, Ho‐Yon Hwang, Haiping Hao, C. Conover Talbot, Jiou Wang · 2012 · Journal of Biological Chemistry
  64. Opposing roles of p38 and JNK in a Drosophila model of TDP-43 proteinopathy reveal oxidative stress and innate immunity as pathogenic components of neurodegeneration
    Lihong Zhan, Qijing Xie, Randal S. Tibbetts · 2014 · Human Molecular Genetics
  65. Integrative transcriptomic analysis suggests new autoregulatory splicing events coupled with nonsense-mediated mRNA decay
    Dmitri Davidovich Pervouchine, Iaroslav Popov, Andy Berry, Beatrice Borsari, Adam Frankish, Roderic Guigó · 2019 · Nucleic Acids Research
  66. The RRM domain of human fused in sarcoma protein reveals a non-canonical nucleic acid binding site
    Xuehui Liu, Chunyan Niu, Jintao Ren, Jia Yu Zhang, Xiaodong Xie, Haining Zhu, Wei Feng, Weimin Gong · 2012 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  67. Transcriptomopathies of pre- and post-symptomatic frontotemporal dementia-like mice with TDP-43 depletion in forebrain neurons
    Lien-Szu Wu, Wei-Cheng Cheng, Chia-Ying Chen, Ming-Che Wu, Yi‐Chi Wang, Yu-Hsiang Tseng, Trees‐Juen Chuang, C.‐K. James Shen · 2019 · Acta Neuropathologica Communications
  68. Pleiotropic requirements for human TDP-43 in the regulation of cell and organelle homeostasis
    Agnes Roczniak-Ferguson, Shawn M. Ferguson · 2019 · Life Science Alliance
  69. Maintaining the balance of TDP-43, mitochondria, and autophagy: a promising therapeutic strategy for neurodegenerative diseases
    Chunhui Huang, Sen Yan, Zaijun Zhang · 2020 · Translational Neurodegeneration
  70. Connecting TDP-43 Pathology with Neuropathy
    Joseph R. Klim, Greta Pintacuda, Leslie A. Nash, Irune Guerra San Juan, Kevin C. Eggan · 2021 · Trends in Neurosciences
  71. TDP‐43 and FUS/TLS: cellular functions and implications for neurodegeneration
    Fabienne C. Fiesel, Philipp J. Kahle · 2011 · FEBS Journal
  72. Pur-alpha regulates cytoplasmic stress granule dynamics and ameliorates FUS toxicity
    J. Gavin Daigle, Karthik Krishnamurthy, Nandini Ramesh, Ian Casci, John Monaghan, Kevin J. McAvoy, Earl W. Godfrey, Dianne C. Daniel, Edward M. Johnson, Zachary T. Monahan et al. · 2016 · Acta Neuropathologica
  73. Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis
    Dara Ditsworth, Marcus Maldonado, Melissa McAlonis‐Downes, Shuying Sun, Amanda Seelman, Kevin Drenner, Eveline S. Arnold, Shuo‐Chien Ling, Donald P. Pizzo, John Ravits et al. · 2017 · Acta Neuropathologica
  74. Amyotrophic lateral sclerosis-associated TDP-43 mutation Q331K prevents nuclear translocation of XRCC4-DNA ligase 4 complex and is linked to genome damage-mediated neuronal apoptosis
    Guerrero, Erika N, Mitra, Joy, Wang, Haibo, Rangaswamy, Suganya, Hegde, Pavana M, Basu, Priyadarshini, Rao, K S, Hegde, Muralidhar L · 2019 · Human Molecular Genetics
  75. Integrating whole-genome sequencing with multi-omic data reveals the impact of structural variants on gene regulation in the human brain
    Ricardo A. Vialle, Kátia de Paiva Lopes, David Alan Bennett, John F. Crary, Towfique Raj · 2022 · Nature Neuroscience
  76. Protein aggregation and therapeutic strategies in SOD1- and TDP-43- linked ALS
    Maria Tsekrekou, Maria Giannakou, Katerina Papanikolopoulou, Γεώργιος Σκρέτας · 2024 · Frontiers in Molecular Biosciences
  77. TDP-43 knockdown impairs neurite outgrowth dependent on its target histone deacetylase 6
    Fabienne C. Fiesel, Christine Schurr, Stephanie S. Weber, Philipp J. Kahle · 2011 · Molecular Neurodegeneration
  78. Distinct multilevel misregulations of Parkin and PINK1 revealed in cell and animal models of TDP-43 proteinopathy
    Xing Sun, Yongjia Duan, Caixia Qin, Jian‐Chiuan Li, Gang Duan, Xue Deng, Jiangxia Ni, Xu Cao, Ke Xiang, Kuili Tian et al. · 2018 · Cell Death and Disease
  79. Tideglusib, a Non-ATP Competitive Inhibitor of GSK-3β as a Drug Candidate for the Treatment of Amyotrophic Lateral Sclerosis
    Loreto Martínez‐González, Claudia Gonzalo‐Consuegra, Marta Gómez‐Almería, Gracia Porras, Eva de Lago, Ángeles Martín‐Requero, Ana Martı́nez · 2021 · International Journal of Molecular Sciences
  80. Lost in local translation: TDP-43 and FUS in axonal/neuromuscular junction maintenance and dysregulation in amyotrophic lateral sclerosis
    Diana Piol, Tessa Robberechts, Sandrine Da Cruz · 2023 · Neuron
  81. TARDBP Mutation Analysis in TDP-43 Proteinopathies and Deciphering the Toxicity of Mutant TDP-43
    Tania F. Gendron, Rosa Rademakers, Leonard Petrucelli · 2012 · Journal of Alzheimer s Disease
  82. Neurodegeneration-associated TDP-43 Interacts with Fragile X Mental Retardation Protein (FMRP)/Staufen (STAU1) and Regulates SIRT1 Expression in Neuronal Cells
    Zhipeng Yu, Dongsheng Fan, Bin Gui, Lei Shi, Chenghao Xuan, Lin Shan, Qian Wang, Yongfeng Shang, Yan Wang · 2012 · Journal of Biological Chemistry
  83. Unraveling the Pathways to Neuronal Homeostasis and Disease: Mechanistic Insights into the Role of RNA-Binding Proteins and Associated Factors
    Stylianos Ravanidis, Fedon-Giasin Kattan, Epaminondas Doxakis · 2018 · International Journal of Molecular Sciences
  84. TDP-43 enhances translation of specific mRNAs linked to neurodegenerative disease
    Nagammal Neelagandan, Giorgio Gonnella, Stefan Dang, Philipp Christoph Janiesch, Katharine K. Miller, Katrin Küchler, Rita F Marques, Daniela Indenbirken, Malik Alawi, Adam T. Grundhoff et al. · 2018 · Nucleic Acids Research
  85. TDP-43-regulated cryptic RNAs accumulate in Alzheimer’s disease brains
    Virginia Estades Ayuso, Sarah R. Pickles, Tiffany W. Todd, Mei Yue, Karen R. Jansen‐West, Yuping Song, Jesús González Bejarano, Bailey D. Rawlinson, Michael A. Deture, Neill R. Graff‐Radford et al. · 2023 · Molecular Neurodegeneration
  86. RNA-Seq Profiling of Spinal Cord Motor Neurons from a Presymptomatic SOD1 ALS Mouse
    Urmi Bandyopadhyay, Justin L. Cotney, Maria Nagy, Sunghee Oh, Jing Leng, Milind C. Mahajan, Shrikant Mane, Wayne A. Fenton, James P. Noonan, Arthur L. Horwich · 2013 · PLoS ONE
  87. Nuclear trafficking in amyotrophic lateral sclerosis and frontotemporal lobar degeneration
    Sonja Prpar Mihevc, Simona Darovic, Anja Kovanda, Ana Bajc Česnik, Vera Župunski, Boris Rogelj · 2016 · Brain
  88. Heavy Metal Neurotoxicants Induce ALS-Linked TDP-43 Pathology
    Peter E.A. Ash, Uma Dhawan, Samantha Boudeau, Shuwen Lei, Yari Carlomagno, Mark Knobel, Louloua F. A. Al-Mohanna, Steven R. Boomhower, M. Christopher Newland, David H. Sherr et al. · 2018 · Toxicological Sciences
  89. TDP-43 and other hnRNPs regulate cryptic exon inclusion of a key ALS/FTD risk gene, UNC13A
    Yuka Mitsuhashi Koike, Sarah R. Pickles, Virginia Estades Ayuso, Karen R. Jansen‐West, Yue Andy Qi, Ziyi Li, Lillian M. Daughrity, Mei Yue, Yong‐Jie Zhang, Casey N. Cook et al. · 2023 · PLoS Biology
  90. Amyotrophic Lateral Sclerosis: New Insights into Underlying Molecular Mechanisms and Opportunities for Therapeutic Intervention
    Mauro Cozzolino, Maria Grazia Pesaresi, Valeria Gerbino, Julian Großkreutz, Maria Teresa Carrı̀ · 2012 · Antioxidants and Redox Signaling
  91. TDP-43 Loss-of-Function Causes Neuronal Loss Due to Defective Steroid Receptor-Mediated Gene Program Switching in Drosophila
    Lies Vanden Broeck, Marina Naval-Sánchez, Yoshitsugu Adachi, Danielle C. Diaper, Pierre Dourlen, Julien Chapuis, Gernot Kleinberger, Marc Gistelinck, Christine Van Broeckhoven, Jean‐Charles Lambert et al. · 2013 · Cell Reports
  92. Mapping Gene Expression in Excitatory Neurons during Hippocampal Late-Phase Long-Term Potentiation
    Patrick B. Chen, Riki Kawaguchi, Charles Blum, Jennifer M. Achiro, Giovanni Coppola, Thomas J. O’Dell, Kelsey C. Martin · 2017 · Frontiers in Molecular Neuroscience
  93. mRNP assembly, axonal transport, and local translation in neurodegenerative diseases
    Bilal Khalil, Dmytro Morderer, Phillip L. Price, Feilin Liu, Wilfried Rossoll · 2018 · Brain Research
  94. Proteome Homeostasis Dysfunction: A Unifying Principle in ALS Pathogenesis
    Justin J. Yerbury, Natalie E. Farrawell, Luke McAlary · 2020 · Trends in Neurosciences
  95. TDP-43 regulates early-phase insulin secretion via CaV1.2-mediated exocytosis in islets
    Kunihiko Araki, Amane Araki, Daiyu Honda, Takako Izumoto, Atsushi Hashizume, Yasuhiro Hijikata, Shinichiro Yamada, Yohei Iguchi, Akitoshi Hara, Kazuhiro Ikumi et al. · 2019 · Journal of Clinical Investigation
  96. Rapamycin alleviates pathogenesis of a new Drosophila model of ALS-TDP
    Ching‐Wei Cheng, Meng-Jau Lin, Che-Kun James Shen · 2015 · Journal of Neurogenetics
  97. Physiological protein aggregation run amuck: stress granules and the genesis of neurodegenerative disease.
    Benjamin L. Wolozin · 2014 · PubMed
  98. RNA‐binding proteins in neurodegenerative disease: TDP‐43 and beyond
    Keith A. Hanson, Sang Hwa Kim, Randal S. Tibbetts · 2011 · Wiley Interdisciplinary Reviews - RNA
  99. FUS-related proteinopathies: Lessons from animal models
    Nicholas A. Lanson, Udai Bhan Pandey · 2012 · Brain Research
  100. Rodent Models of TDP-43 Proteinopathy: Investigating the Mechanisms of TDP-43-Mediated Neurodegeneration
    Tania F. Gendron, Leonard Petrucelli · 2011 · Journal of Molecular Neuroscience